期刊
NEUROSCIENCE LETTERS
卷 322, 期 1, 页码 13-16出版社
ELSEVIER SCI IRELAND LTD
DOI: 10.1016/S0304-3940(02)00069-1
关键词
dopamine; dopamine transporter; A(2A) adenosine receptor; locomotion; neuroprotection; striatum
资金
- NIA NIH HHS [AG18167] Funding Source: Medline
- NIEHS NIH HHS [ES10804] Funding Source: Medline
- NINDS NIH HHS [NS37403] Funding Source: Medline
We investigated the effect of chronic daily caffeine treatment on caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity. Mice received either caffeine (20 mg/kg) or saline daily for 9 days. Caffeine-induced locomotion tolerance developed within 3 days of treatment and persisted for the duration of the experiment. On day 10, mice were treated with MPTP (20 mg/kg, x 4). Caffeine (20 mg/kg) or saline was administered 10 min before each MPTP dose. Acute pretreatment with caffeine attenuated MPTP-induced loss of striatal dopamine and dopamine transporter binding sites, and this attenuation was identical in mice pretreated chronically with caffeine or with saline. Thus, in contrast to the locomotor stimulant effect of caffeine, its neuroprotectant effect did not show tolerance to prior caffeine exposure. These data raise the possibility that caffeine may induce neuroprotection and locomotion by distinct mechanisms. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据